scholarly journals Editorial: Gut Microbial Response to Host Metabolic Phenotypes

2022 ◽  
Vol 8 ◽  
Author(s):  
Jie Yin ◽  
Yong Su ◽  
Hui Han
2016 ◽  
Vol 94 (suppl_5) ◽  
pp. 87-88
Author(s):  
M. A. Crookenden ◽  
C. G. Walker ◽  
A. Heiser ◽  
J. J. Loor ◽  
K. M. Moyes ◽  
...  

2018 ◽  
Author(s):  
Tim Hollstein ◽  
Takafumi Ando ◽  
Alessio Basolo ◽  
Jonathan Krakoff ◽  
Susanne Votruba ◽  
...  

2020 ◽  
Vol 21 (13) ◽  
pp. 1031-1039
Author(s):  
Suping Niu ◽  
Yan Li ◽  
Wenliang Dong ◽  
Lin Xia ◽  
Tiantian Shen ◽  
...  

Background: Desloratadine is a drug with a phenotypic polymorphism in metabolism and has been approved for use in many countries to treat allergic diseases. CYP2C8 and UGT2B10 are metabolic enzymes, which may be involved in the metabolism of desloratadine. Objective: This study aimed to demonstrate bioequivalence between the test product (desloratadine tablet) and the reference product AERIUS (5mg), both orally administered. And the role of UGT2B10 and CYP2C8 genotypes in healthy Chinese subjects with different Desloratadine metabolic phenotypes was examined. Methods: It was a randomized, open-label, and four-sequence, single-dose crossover study conducted on 56 healthy Chinese subjects. The pharmacokinetics (PK) and safety of the test and reference Desloratadine products were compared. UGT2B10 and CYP2C8 genotypes were determined by the TaqMan assay using genomic DNA. Multiple linear regression was applied to analyze the correlation between genotypes and the metabolic ratio. Results: The mean serum concentration-time curves of desloratadine and 3-OH-desloratadine were similar between the test product and the reference product. For the PK similarity comparison, the 90% CIs for the geometric mean ratios of Cmax, AUC0-t, and AUC0-∞ of desloratadine and 3-OH-desloratadine of test and reference product were completely within 80-125%. None of all 56 subjects had serious adverse events. Only 2 subjects were poor-metabolizers in 56 healthy subjects. There was no significant correlation between investigated genotypes of CYP2C8 and UGT2B10 and the metabolic ratio. Conclusion: The test desloratadine tablet was bioequivalent to the reference product. No direct relationship between CYP2C8 and UGT2B10 genotypes and desloratadine metabolic ratio was identified.


Water ◽  
2021 ◽  
Vol 13 (4) ◽  
pp. 481
Author(s):  
Sarah A. Morley ◽  
Linda D. Rhodes ◽  
Anne E. Baxter ◽  
Giles W. Goetz ◽  
Abigail H. Wells ◽  
...  

All cities face complex challenges managing urban stormwater while also protecting urban water bodies. Green stormwater infrastructure and process-based restoration offer alternative strategies that prioritize watershed connectivity. We report on a new urban floodplain restoration technique being tested in the City of Seattle, USA: an engineered hyporheic zone. The hyporheic zone has long been an overlooked component in floodplain restoration. Yet this subsurface area offers enormous potential for stormwater amelioration and is a critical component of healthy streams. From 2014 to 2017, we measured hyporheic temperature, nutrients, and microbial and invertebrate communities at three paired stream reaches with and without hyporheic restoration. At two of the three pairs, water temperature was significantly lower at the restored reach, while dissolved organic carbon and microbial metabolism were higher. Hyporheic invertebrate density and taxa richness were significantly higher across all three restored reaches. These are some of the first quantified responses of hyporheic biological communities to restoration. Our results complement earlier reports of enhanced hydrologic and chemical functioning of the engineered hyporheic zone. Together, this research demonstrates that incorporation of hyporheic design elements in floodplain restoration can enhance temperature moderation, habitat diversity, contaminant filtration, and the biological health of urban streams.


2021 ◽  
pp. 108307
Author(s):  
Suvendu Das ◽  
Hyun Young Hwang ◽  
Hyeon Ji Song ◽  
Song Rae Cho ◽  
Joy D. Van Nostrand ◽  
...  

Diabetologia ◽  
2005 ◽  
Vol 48 (5) ◽  
pp. 886-891 ◽  
Author(s):  
A. Bennett ◽  
U. Sovio ◽  
A. Ruokonen ◽  
H. Martikainen ◽  
A. Pouta ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document